Thursday, May 02, 2013 7:00:06 PM
Last Price High Low Total Chg $Qty Mkt Value
SCTN 0.001 0.001 0.001 +91.40 228,500 228.50
Quantity Acquired Date Holding Period
$SCTN 228,500 03/19/2013 Short Term (321)
Gains
Cost Market Price Market Value Unrealized % Gain/Loss
$0.0004 $98.86 $0.0010 $228.50 $129.64 131.13%
4/12/2013 my opinion a easy pop was in order. Now I like to see follow through for the next two trading days.
Below I reviewed my favorite Indicators and Overylays
Indicators all in agreement with the current up trend yea..\(??)/
RSI is overbought
1.Parabolic Sar positive trending up
2.FORCE INDEX confirms trend +45.7
3.AROON confirms trend +100
4.MACD Hist confirms trend
5.MACD confirms trend
6.ADX confirms trend +DI 87.58
7.CCI confirms trend above 50 @ 326.15
8.Full STO confirms trend 66.67
9.True Strength confirms trend 48.2
10.Correlation $Spx .50 +trending
11.Price Performance Vs $SPX +2.83%
12.On Balance +Up
13.(KST)Know Sure Thing +364.78
14.Pivot Point price above pivot 2R @.011
Overlays in agreement
MA 10 X 50 cross-over 4/25/2013 above it's 50 day moving avg
Price is above these channels
*Keltner
*Price
*Chandelier Exits
Cheat Sheet
http://www.barchart.com/cheatsheet.php?sym=SCTN
1 month daily
http://stockcharts.com/h-sc/ui?s=SCTN&p=D&yr=0&mn=1&dy=0&id=p82707346580
$SCTN cruised through the Ichimoku Cloud as the Kumo turning bullish because the Senkou span B/Blueline Crossed-over apx on 4/16/2013 Senkou span A/redline with the Parabolic Sars confirming a start of an uptrend mid April/2013
Kijun Sen greenline...is pointing to the MOON Let's go!!
Shareholders "this is your captain speaking please turn off your iphones, snap your seatbelts.
Please put your seat in the upright position, and buy as many shares that you can with all of the indicators and overlays in agreement the price might go past the moon maybe MARS"
I am your Captain Technically Speaking (??)
Follow through Buying volume is needed for momentum to kick in the supply and demand.....
$SCTN we can do this (??)
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM